Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TOP2A, TOP2, TP2A AND Prognosis
11 results:

  • 1. Identification of potential key genes for colorectal cancer based on bioinformatics analysis.
    Li C; Cao S; Guo M; Guo A; Sun X
    Medicine (Baltimore); 2023 Dec; 102(51):e36615. PubMed ID: 38134110
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics.
    Liu Y; Yang Y; Ni F; Tai G; Yu C; Jiang X; Wang D
    J Transl Med; 2023 Nov; 21(1):856. PubMed ID: 38012642
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
    Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. UPF1 promotes chemoresistance to oxaliplatin through regulation of top2a activity and maintenance of stemness in colorectal cancer.
    Zhu C; Zhang L; Zhao S; Dai W; Xu Y; Zhang Y; Zheng H; Sheng W; Xu Y
    Cell Death Dis; 2021 May; 12(6):519. PubMed ID: 34021129
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
    Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
    Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
    Serna G; Ruiz-Pace F; Cecchi F; Fasani R; Jimenez J; Thyparambil S; Landolfi S; Elez E; Vivancos A; Hembrough T; Tabernero J; Dienstmann R; Nuciforo P
    Sci Rep; 2019 Sep; 9(1):13568. PubMed ID: 31537838
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Overexpression of Topoisomerase 2-Alpha Confers a Poor prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
    Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
    Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer.
    Nygård SB; Christensen IJ; Smith DH; Nielsen SL; Jensen NF; Nielsen HJ; Vainer B; Brünner N
    Scand J Gastroenterol; 2013 Dec; 48(12):1436-43. PubMed ID: 24138107
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.